I agree that this site is using cookies. You can find further informations here.
X
Mack, Philip C.
177  results:
OpenAccess-fulltext X
Search for persons X
?
1

Serological Response to SARS-CoV-2 after COVID-19 Vaccinati..:

Rodilla, Ananda M ; Tavolacci, Sooyun ; Cagan, Jazz...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223259/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Targeted Next-Generation Sequencing Reveals Exceptionally H..:

Mack, Philip C ; Klein, Michael I ; Ayers, Kristin L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177106/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

Extracellular vesicle PD-L1 dynamics predict durable respon..:

de Miguel-Perez, Diego ; Russo, Alessandro ; Arrieta, Oscar...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161571/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

A phase I dose escalation, dose expansion and pharmacokinet..:

Chen, Justin A ; Huynh, Jasmine C ; Wu, Chun-Yi...
qt77s0g00d.  , 2022
Link: https://escholarship.org..
 
?
5

A Genomically and Clinically Annotated Patient-Derived Xeno..:

Woo, Xing Yi ; Srivastava, Anuj ; Mack, Philip C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664138/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Extracellular vesicle PD-L1 dynamics predict durable respon..:

de Miguel-Perez, Diego ; Russo, Alessandro ; Arrieta, Oscar...
http://hdl.handle.net/10668/20349.  , 2022
Link: http://hdl.handle.net/10..
 
?
7

A phase I dose escalation, dose expansion and pharmacokinet..:

Chen, Justin A ; Huynh, Jasmine C ; Wu, Chun-Yi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402746/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

Circulating tumor DNA (ctDNA) kinetics predict progression-..:

Mack, Philip C ; Miao, Jieling ; Redman, Mary W...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444942/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

A Genomically and Clinically Annotated Patient-Derived Xeno..:

Woo, Xing Yi ; Srivastava, Anuj ; Mack, Philip C...
qt1zw6561t.  , 2022
Link: https://escholarship.org..
 
?
10

Extracellular vesicle PD-L1 dynamics predict durable respon..:

de Miguel-Perez, Diego ; Russo, Alessandro ; Arrieta, Oscar...
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request..  , 2022
Link: http://hdl.handle.net/10..
 
?
11

Baseline extracellular vesicle TGF-β is a predictive biomar..:

de Miguel Perez, Diego ; Russo, Alessandro ; Gunasekaran, Muthukumar...
Cancer, 1097-0142, 129, 4, 2023, 521-530.  , 2022
Link: https://hdl.handle.net/2..
 
?
12

Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treat..:

Gettinger, Scott N ; Redman, Mary W ; Bazhenova, Lyudmila...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283667/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
13

Phase II study of durvalumab plus tremelimumab as therapy f..:

Leighl, Natasha B ; Redman, Mary W ; Rizvi, Naiyer...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386207/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
14

Phase I/II Study of Capmatinib Plus Erlotinib in Patients W..:

McCoach, Caroline E ; Yu, Aiming ; Gandara, David R...
qt9bj424n7.  , 2021
Link: https://escholarship.org..
 
?
15

A Phase II Study of Talazoparib in Patients with Homologous..:

Owonikoko, Taofeek K ; Redman, Mary W ; Byers, Lauren A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637652/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15